|Bid||0.7992 x 1000|
|Ask||0.8257 x 800|
|Day's Range||0.7401 - 0.8350|
|52 Week Range||0.6300 - 8.8800|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Represents Approximately 30% of Jupiter Wellness's Outstanding Shares at current market priceJUPITER, FL / ACCESSWIRE / January 25, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it its board of directors approved a $5.
SRM Entertainment to raise up to $10 million and seek listing on Nasdaq Creates a "Pure Play" Drug Developer in Jupiter Wellness upon the Completion of its Pending Merger with Next Frontier PharmaceuticalsJUPITER, FL / ACCESSWIRE / January 24, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it intends to dividend its wholly-owned subsidiary, SRM Entertainment to its stockholders in conjunction with Jupiter Wellness' merger with Next Frontier Pharmaceuticals, Inc.
Next Frontier Pharmaceuticals' Subsidiary Benuvia Signs Agreement with Global Wellness' Shanti Therapeutics * Benuvia has begun focusing on Psilocybin, DMT, and MDMA. * Benuvia's 83,000 square foot synthetic compound manufacturing facility is permitted by the U.